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LETTERS
Flaviviruses in 
Game Birds,  
Southern Spain, 
2011–2012
To the Editor: Certain arthro-
pod-borne epornitic flaviviruses, 
namely, West Nile virus (WNV) and 
Usutu virus (USUV), have spread 
recently in parts of Europe (1,2). In 
southern Spain, the emergence of 
a third virus of this type, known as 
Bagaza virus (BAGV), is of concern 
(3). Because of the outbreaks in 2010 
in Cádiz (southern Spain) of WNV in-
fection, which affected birds, horses, 
and humans, and of BAGV infection, 
which affected game birds (partridges 
and pheasants), and the reported pres-
ence of USUV in mosquitoes in this 
area (4), a surveillance program was 
implemented in partridges and pheas-
ants during the next hunting season 
(October 2011–February 2012) to as-
sess the possible circulation of these 3 
flaviviruses in the area.
Serum samples and brain tissue 
from 159 hunted-harvested wild red-
legged partridges (Alectoris rufa) and 
13 common pheasants (Phasianus col-
chicus) were collected on 12 hunting 
properties from Cádiz (online Techni-
cal Appendix Figure, wwwnc.cdc.gov/
EID/article/19/6/13-0122-Techapp1.
pdf]). All sampled birds were reared 
and shot in the wild. The age of the 
partridges was determined according 
to plumage characteristics.
Presence of antibodies against 
WNV was tested with a commercial 
epitope-blocking ELISA (Ingezym 
West Nile Compac, INGENASA, 
Madrid, Spain) (5). Virus-neutral-
ization titers against WNV (strain 
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Table.	Results	of	serologic	studies	in	red-legged	partridges	and	common	pheasants,	southern	Spain,	2011–2012* 
Species,	no. Age ELISA,	WNV 
VNT	titers†  
WNV BAGV USUV Interpretation‡ 
Partridges (Alectoris rufa),	n	=	159       
 6 Juvenile + 10–20 5 5 WNV 
 7 Adult + 10–20 5 5 WNV 
 1 Adult + 160 20 20 WNV 
 4 Not	determined + 10–80 5 5 WNV 
 1 Not	determined + 80 5 10 WNV 
 2 Juvenile + 10 40 5 BAGV 
 1 Juvenile + 20 80 10 BAGV 
 1 Juvenile – 5 160 10 BAGV 
 2 Adult + 20, 40 80, 320 10 BAGV 
 1 Adult + 5 20 5 BAGV 
 1 Adult + 10‡ 40 10‡ BAGV 
 1 Adult – 5 40 5 BAGV 
 1 Adult + 5 5 40 USUV 
 2 Juvenile + 10, 20 20, 40 5 Flavivirus 
 3 Adult + 5 5 5 Flavivirus 
 2 Adult + 20, 80 80, 160 40 Flavivirus 
 1 Adult + 20 5 10 Flavivirus 
 1 Adult + 160 20‡ 80 Flavivirus 
 1 Adult + 40 40 10‡ Flavivirus 
 1 Adult – 10‡ 20 10‡ Flavivirus 
 3 Not	determined + 5 5 5 Flavivirus 
 1 Not	determined + 5 10 5 Flavivirus 
Pheasants (Phasianus colchicus),	n	=	13       
 1 Adult + 80 20 10 WNV 
 2 Not	determined + 10, 20 5 5 WNV 
 2 Adult + 10, 80 80, 640 20 BAGV 
 1 Adult – 5 20 5 BAGV 
 3 Adult + 20–40 20–160 40–160 Flavivirus 
 1 Adult + 10 5 5 Flavivirus 
 1 Adult – 5 10 5 Flavivirus 
 1 Adult Not	determined 20‡ 20‡ 40 Flavivirus 
Positive,	no.	(%)       
 Partridges 40	(25) 31	(19) 17	(11) 11	(7)  
 Pheasants 9	(69) 9	(69) 8	(62) 7	(54)  







‡VNT at the indicated (or lower) dilution(s) could not be determined because of cytotoxic effect caused by the sample. 
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Eg-101), BAGV (strain Spain/2010), 
and USUV (strain SAAR1776) were 
determined by micro virus neutraliza-
tion test (VNT) as described (6).
Viral genome in brain tissue 
samples was examined by heminested 
pan-flaviviral reverse transcription 
PCR (7). All 172 tissue homogenates 
examined were negative by this test.
Overall seroprevalence for WNV 
by epitope-blocking ELISA was 29%. 
Prevalence of neutralizing antibodies 
measured by VNT was 23% for WNV, 
15% for BAGV, and 10% for USUV. 
Seroprevalence rates were higher for 
pheasants than for partridges for WNV 
(Fisher exact test, p = 0.0003), BAGV 
(p<0.0001), and USUV (p<0.0001) 
(Table). The significance of this result 
is uncertain, given that just 2 hunting 
areas were sampled for pheasants.
Neutralizing antibodies to >1 fla-
vivirus were detected in 15 of the 45 
VNT-positive partridges and in 6 of the 
12 VNT-positive pheasants (Table). 
Specificity, as determined by neutral-
izing antibodies titer comparisons (8), 
showed virus-specific neutralizing an-
tibodies to WNV, BAGV, and USUV 
in 19 partridges, 9 partridges, and 1 
partridge, respectively, in 3 pheasants 
to WNV and in another 3 pheasants 
to BAGV (0 to USUV). Serum from 
9 partridges and 6 pheasants remained 
inconclusive (neutralizing antibodies 
titer differences <4-fold [8]). WNV-
reacting antibodies by ELISA were 
shown in 11 of 12 hunting properties 
(online Technical Appendix Figure). 
In all locations but 1, ELISA-positive 
results were confirmed by VNT for 
NT-Abs to WNV, BAGV, or USUV. 
Of them, neutralizing antibodies to 
only WNV were detected in 2 loca-
tions, whereas neutralizing antibodies 
to at least 2 (WNV/USUV or WNV/
BAGV) of the 3 flaviviruses were 
detected in 8 locations. Within these 
locations, flavivirus-specific NT-Ab 
responses were differentiated in sever-
al samples: neutralizing antibodies to 
either WNV or BAGV were detected 
in samples from 6 locations, whereas 
samples with neutralizing antibodies 
to either WNV or USUV were detect-
ed in 1 location.
Analysis of VNT results in juve-
nile partridges showed specific neu-
tralizing antibodies to WNV (13%) 
or BAGV (9%); 4% of these samples 
were positive for flavivirus but in-
conclusive for any of the flaviviruses 
tested (Table). Overall, these results 
indicated recent circulation of 3 dif-
ferent epornitic flaviviruses—WNV, 
USUV, and BAGV—in resident game 
birds in Cádiz, the southernmost prov-
ince in Spain. A high proportion of 
birds showed neutralizing antibodies 
to >1 flavivirus. Some are likely to 
be attributable to cross-neutralization, 
although co-infection cannot be ruled 
out because the results showed co-cir-
culation of >1 flavivirus in game birds 
in most locations studied. Further-
more, the presence of specific neutral-
izing antibodies in juvenile partridges 
indicated that WNV and BAGV circu-
lated in the area 1 year after the out-
breaks of 2010. For USUV, specific 
neutralizing antibodies were detected 
only in an adult partridge, indicating 
infection acquired during the previous 
years. Nevertheless, this finding does 
not rule out recent co-circulation of 
USUV together with the other 2 virus-
es in the same game bird populations, 
considering that USUV has been re-
peatedly detected in mosquitoes in 
nearby areas (4).
Evidence of infection by at least 
WNV and BAGV in 2 consecutive 
seasons strongly supports the prem-
ise that these viruses overwintered in 
the area. Capability of WNV to over-
winter in southern Europe was shown 
in Italy during 2008–2009 (9) and in 
Spain during 2007–2008 (10). Over-
wintering of BAGV after its introduc-
tion into Spain could indicate a risk for 
its expansion in areas with similar cli-
mates (Mediterranean basin). The risk 
for dissemination of WNV, BAGV, 
or USUV infections not only to game 
birds, but also to other wildlife, do-
mestic animals, and humans, calls for 
improvements in surveillance pro-
grams, particularly those that monitor 
susceptible hosts, such as game birds.
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Absence of  
Rift Valley Fever 
Virus in Wild Small 
Mammals,  
Madagascar
To the Editor: Rift Valley fever 
virus (RVFV) is a mosquito-borne 
zoonotic virus in the family Bunya-
viridae, genus Phlebovirus, which af-
fects mainly domestic ruminants and 
humans on continental Africa, Mada-
gascar, and the Arabian Peninsula (1). 
RVFV is transmitted between rumi-
nants mainly by bites of mosquitoes of 
several genera (1). Infection can lead 
to mild symptoms or can cause abor-
tion in pregnant animals and high mor-
tality rates among newborns. Humans 
are mostly infected by aerosol trans-
mission when handling infected tissues 
(aborted fetuses or meat), which results 
in dengue-like illness. Some cases in 
humans can be in a severe form (hem-
orrhagic fever and meningoencephali-
tis), which can be fatal. Outbreaks in 
southern and eastern Africa are associ-
ated with periods of heavy rainfall (1). 
In eastern Africa, RVFV is believed to 
be maintained during interepizootic 
periods through vertical transmission 
in Aedes spp. mosquitoes (1). It has 
been suspected that wild mammals, 
especially rodents, play a role in the 
maintenance of RVFV during interepi-
zootic periods (2). However, evidence 
of a wild mammal reservoir in the epi-
demiologic cycle of RVFV has yet to 
be demonstrated (2).
In Madagascar, the first RVFV 
isolate was obtained from mosquitoes 
captured in the Périnet Forest (Anda-
sibe, Moramanga District) in 1979, 
outside an epizootic period (3). Two 
epizootic episodes occurred, during 
1990–91 and 2008–09 (4). After the 
most recent episode, domestic rumi-
nants were shown to be involved in 
RVFV circulation during interepizo-
otic periods (5,6); together with the 
potential vertical transmission in Ae-
des spp. mosquitoes in Madagascar, 
they might play a role in the mainte-
nance of RVFV. However, genetic evi-
dence indicates that RVFV outbreaks 
in Madagascar are not associated with 
emergence from enzootic cycles but 
that they are associated with recur-
rent virus introductions from main-
land east Africa (7). Although these 
mechanisms for RVFV epidemiology 
on Madagascar are documented, the 
possibility of a wild mammal reser-
voir cannot be excluded. We therefore 
explored the role of wild terrestrial 
small mammals in the maintenance of 
RVFV in Madagascar, especially the 
nonnative, abundant, and ubiquitous 
black rats (Rattus rattus) (8), as has 
been suggested in rural Egypt (9,10).
For this study, 1,610 blood sam-
ples were obtained from different spe-
cies of wild terrestrial small mammals 
in Madagascar (Figure). Permits to 
capture and collect animals were ob-
tained from national authorities. Ani-
mals were sampled from October 2008 
through March 2010 at a site in the 
Anjozorobe-Angavo (Anjozorobe Dis-
trict) forest corridor (18°18′′41.9′ S, 
48°00′′57.6′ E), where RVFV was first 
detected in humans and cattle in Febru-
ary 2008 (4) and within 100 km from 
where the first RVFV was isolated in 
1979 (3). We collected 378 serum sam-
ples from 11 native Tenrecidae (Af-
rosoricida) tenrecs, 114 samples from 6 
native Nesomyidae (Rodentia) rodents, 
and 471 samples from introduced R. 
Rattus (Muridae, Rodentia) rats (online 
Technical Appendix, wwwnc.cdc.gov/
EID/article/19/6/12-1074-Techapp1.
pdf). In addition, during 2008, we ob-
tained serum samples from 647 R. rat-
tus or R. norvegicus rats living near 
humans in areas where RVFV was 
reportedly circulating during 2008 and 
2009: the districts of Ankazobe, An-
tsiranana, Betafo, Ihosy, Marovoay, 
and Moramanga (4,5) (Figure).
Serum samples were tested for 
IgG against RVFV by ELISA, as 
described (4), by using peroxidase-
labeled recombinant protein A/G 
(Pierce, Rockford, IL, USA) or 
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